BioScavenge ApS Financials, key figures and credit report
Gross profit 2 509.0 kDKK FY 2025 +66.7% vs 2024
EBIT -75.1 kDKK FY 2025 +93.8% vs 2024
Net debt 528.5 kDKK FY 2025 +651.6% vs 2024
Quick ratio 1.1 FY 2025 -0.6 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 819.66 | 3 220.37 | 3 306.92 | 1 505.44 | 2 508.99 |
| Employee benefit expenses | -1 716.61 | -3 006.33 | -3 643.61 | -2 466.59 | -2 113.11 |
| Total depreciation | -4.16 | -22.62 | - 346.78 | - 249.61 | - 470.98 |
| EBIT | 98.90 | 191.43 | - 683.47 | -1 210.76 | -75.10 |
| Other financial income | 0.03 | 0.51 | 5.64 | 4.14 | 0.87 |
| Other financial expenses | -38.86 | -16.46 | -5.67 | -6.79 | -59.24 |
| Pre-tax profit | 60.06 | 175.47 | - 683.50 | -1 213.42 | - 133.47 |
| Income taxes | -26.68 | 24.50 | 154.59 | 236.03 | 90.80 |
| Net earnings | 33.39 | 199.97 | - 528.90 | - 977.39 | -42.67 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Development expenditure | 959.10 | 1 034.05 | 1 599.89 | 2 468.18 | |
| Intangible assets total | 959.10 | 1 034.05 | 1 599.89 | 2 468.18 | |
| Machinery and equipment | 35.78 | 721.40 | 566.44 | 415.64 | 273.99 |
| Tangible assets total | 35.78 | 721.40 | 566.44 | 415.64 | 273.99 |
| Investments total | 37.56 | 38.96 | 38.96 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 435.96 | 847.03 | 340.94 | 520.25 | |
| Current owed by particip. interest comp. | 245.29 | 453.53 | |||
| Prepayments and accrued income | 1.14 | 37.50 | 19.51 | ||
| Current other receivables | 16.86 | 32.15 | 66.30 | 481.49 | 36.68 |
| Current deferred tax assets | 237.82 | 127.07 | 146.22 | 234.06 | |
| Short term receivables total | 698.10 | 1 571.67 | 230.87 | 968.65 | 810.49 |
| Cash and bank deposits | 2 510.93 | 642.05 | 1 674.79 | 720.82 | 124.68 |
| Cash and cash equivalents | 2 510.93 | 642.05 | 1 674.79 | 720.82 | 124.68 |
| Balance sheet total (assets) | 3 244.81 | 3 894.22 | 3 543.70 | 3 743.95 | 3 716.30 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| Other reserves | 748.10 | 806.56 | 1 247.91 | 1 925.18 | |
| Retained earnings | 2 413.98 | 1 699.27 | 1 840.78 | 2 245.52 | 590.87 |
| Profit of the financial year | 33.39 | 199.97 | - 528.90 | - 977.39 | -42.67 |
| Shareholders equity total | 2 697.37 | 2 897.34 | 2 368.43 | 2 766.05 | 2 723.37 |
| Provisions | 1.28 | 184.61 | 89.81 | 139.26 | |
| Non-current other liabilities | 139.71 | ||||
| Non-current deferred tax liabilities | 142.65 | ||||
| Non-current liabilities total | 139.71 | 142.65 | |||
| Current trade creditors | 205.79 | 460.87 | 317.26 | 95.58 | 66.25 |
| Current owed to participating | 625.00 | 653.22 | |||
| Short-term deferred tax liabilities | 19.40 | ||||
| Other non-interest bearing current liabilities | 181.27 | 208.77 | 379.73 | 257.33 | 134.20 |
| Accruals and deferred income | 388.47 | ||||
| Current liabilities total | 406.45 | 669.64 | 1 085.46 | 977.91 | 853.67 |
| Balance sheet total (liabilities) | 3 244.81 | 3 894.22 | 3 543.70 | 3 743.95 | 3 716.30 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated